Company / Free Cash Flow
AbbVie Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$17.8B
FY2025
5-year range
$17.8B / $24.2B
FY2021-FY2025
Trend
-0.1%
vs FY2024
Sector context
#2 of 192
Health Care
What the data says
Among 192 Health Care companies, AbbVie is in the top 1% for free cash flow. Free Cash Flow has declined for 3 consecutive years, from $24.2B in FY2022 to $17.8B in FY2025.
Based on SEC 10-K filings.
$17.8B in FY2025 with a 5-year CAGR of +1.2%. Ranks 2nd among 192 companies in Health Care.
Declined from $22.1B to $17.8B over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -9.8%
- 5-Year CAGR
- +1.2%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 192This company $17.8B Sector average $474.2M
▼
+3657.4% above sector average
Key checks
Key Insights
- AbbVie's free cash flow has declined for 3 consecutive years.
- 5-year CAGR of +1.2%, indicating consistent growth.
- In FY2025, free cash flow decreased 0.1% year-over-year.
- Ranks #2 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.8B | -0.1% |
| FY2024 | $17.8B | -19.2% |
| FY2023 | $22.1B | -9.0% |
| FY2022 | $24.2B | +10.3% |
| FY2021 | $22.0B | +31.0% |
| FY2020 | $16.8B | +31.5% |
| FY2019 | $12.8B | -0.1% |
| FY2018 | $12.8B | +35.6% |
| FY2017 | $9.4B | +43.7% |
| FY2016 | $6.6B | -6.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026